At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 100 target
Drug / intervention
Epidural Spinal Cord Stimulationdevice
Likely dose
Not stated in record
Key inclusion· 10
- ✓Age 22 or older
- ✓Motor-complete paraplegia
- ✓Spinal cord injury C6 to T10
- ✓ASIA A or B classification
Key exclusion· 14
- ✕Cardiopulmonary disease increasing surgical risk
- ✕Cannot withhold antiplatelet/anticoagulation agents perioperatively
- ✕Significant dysautonomia or history of CVA/MI with autonomic dysreflexia
- ✕Abnormal tilt table test (syncope, presyncope, SBP <50 or >200)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Epidural Stimulation for Spinal Cord Injury
In Brief
A clinical study evaluating Epidural Spinal Cord Stimulation for Spinal Cord Injuries and Paraplegia, Complete. Currently recruiting, targeting 100 participants across 1 site.
Detailed Summary
This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injuries, Paraplegia, Complete
CountriesUnited States
Timeline
N/ARecruiting
201720182019202020212022202320242025202620272028
First PostedJan 2017
Enrollment StartAug 2017
TodayJul 2026
Primary CompletionJan 2027
Study CompletionJan 2028
First PostedJan 20, 2017
Enrollment StartAug 7, 2017
Primary CompletionJan 1, 2027
Study CompletionJan 1, 2028
TodayJul 2, 2026
Enrollment to primary: 9.4 yearsPosted 9.5 years agoPrimary completion in 6 months
Interventions
Epidural Spinal Cord Stimulationdevice
epidural spinal cord stimulator